Patients drop MS drug, face relapse risk
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.
Latest study says regular follow-up positive. Scientist say there is an urgent need for research into all aspects of follow-up care in lung cancer. The study presented in… read more.
Like special-forces troops laser-tagging targets for a bomber pilot, tiny particles that can be imaged three different ways at once have enabled Stanford University School of Medicine scientists… read more.
by Dr Sunil Upadhyay – Basal cell carcinoma is the most common malignancy in the world. Its incidence is common in people with fair skin due to excessive… read more.
by Dr Sunil Upadhyay – One of the most important advances in cancer research over the last decade or so has been the appearance of targeted therapies. It… read more.
by Dr Sunil Upadhyay – It would be difficult to imagine how one would treat breast cancer today if it was not for the work and leadership of… read more.
by Professor John Dark (pictured) – In contrast with that other thoracic organ the heart, activity and optimism in the pulmonary field are both increasing. Contemporay outcomes for… read more.
FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – A Study published on Dec. 20, 2011 in the British Medical Journal suggests that some children… read more.
Taken from the Journal of the American Medical Association (JAMA) – by Bruce Sylvester – Systolic hypertension patients treated in a clinical trial with the diuretic chlorthalidone for… read more.
EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed. The document provides guidance… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.